Theravance Biopharma Cut to Neutral From Buy by BTIG
Dow Jones Newswires
Theravance Biopharma Cut to Neutral From Buy by BTIG
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:TBPH
- Language
- English
Theravance Biopharma Cut to Neutral From Buy by BTIG